bosley
- 20 Feb 2004 09:34
hewittalan6
- 25 May 2007 14:44
- 24467 of 27111
showing your age.
only being 27, I have seen it on UKTV Gold ;-)
automatic
- 25 May 2007 14:52
- 24468 of 27111
my mum told me all about it??
automatic
- 25 May 2007 14:54
- 24469 of 27111
na twas good that one, don't make em like that anymore, how long before someone posts(thank *&%$# for that
automatic
- 25 May 2007 15:07
- 24471 of 27111
alan, i will have to show my neighbour these phots, i reckon he's Catweasels brother, frightning i didn't realise how ugly he was
TopAnalyst
- 25 May 2007 20:15
- 24472 of 27111
WOODIE
- 29 May 2007 07:15
- 24474 of 27111
Stanelco PLC
29 May 2007
29th May 2007
Stanelco plc('Stanelco' or 'the Company')
Trading Statement
Following the appointment of Paul Mines as Chief Executive Officer of the
Company on 16 April 2007, a preliminary review of the business operations of the
Company has been conducted. The results of that review were presented to the
Board on 25 May 2007.
The principal conclusions from the review are as follows:
1. Biotec
Biotec, which is owned 50 per cent. by Stanelco and 50 per cent. by SPhere S.A.,
sells virtually all of its biopolymer output to its shareholders. In the current
financial year to 31 December 2007, it was envisaged that each shareholder would
take approximately half of the production capacity of biopolymer and Biotec has
prepared itself for that eventuality. However, the Stanelco sales and product
pipeline is currently nascent and is expected to be developed over the course of
the next 18 months or so.
Given this, and other strategic constraints, the plans to manufacture Biotec
materials in the USA have been placed on hold.
In addition, the Board has become aware of certain patent challenges lodged
against some of Biotec's products and is currently evaluating the significance
of these challenges.
2. Radio Frequency (RF) Applications
The Greenseal trials have now been concluded. Unfortunately, the Board's
assessment of the result of these trials is that they are unlikely to lead to
any commercial sales for this particular application. Underlying trading at the
RF division remains steady.
3. Aquasol
An agreement has been reached to sell certain assets of Adept to MonoSol AF
Limited for approximately 494,000 and this may lead to the possible future
licensing of Aquasol's FrogMat intellectual property. Shareholders will be kept
fully informed of further developments in this regard.
Development continues to commercialise other Aquasol intellectual property.
4. Cash flow
Our cash balance at 30 April 2007 was approximately 11 million. We are
committed to ensure that these funds are deployed successfully towards a cash
positive trading position. Accordingly, the cost base of the business is being
kept under review and further cost reductions are envisaged.
Trading expectations for this financial year will be adversely affected by the
above.
The Board remains encouraged by market trends and customer interest in the
Company's portfolio of products and intellectual property and is developing its
plans in the short term to deliver shareholder value from these assets over the
medium term.
A full trading update will be provided with the half year results.
For further information please contact:
Financial Dynamics
Jonathon Brill/Caroline Stewart
Tel: +44 (0) 20 7831 3113
This information is provided by RNS
The company news service from the London Stock Exchange
Mad Pad
- 29 May 2007 07:22
- 24475 of 27111
Looks bloody awful to me.
Positive Trader
- 29 May 2007 07:33
- 24476 of 27111
This is bloody awful!The two products that were going to be the good news for this Company are now being shelved -1. no biopolymer output in the states.2.Greenseal which should have changed the packaging industry has no commercial sales.
This will take a lot to recover from in the short term and also Biotec products in dispute so that could drag on for ages
pt.not so positive today well here anyway.
greekman
- 29 May 2007 07:51
- 24478 of 27111
So promises, promises have come to nothing....BUT....... "The Board remains encouraged by market trends and customer interest in the company's portfolio of products and intellectual property and is developing its plans in the short term to deliver shareholder value from these assets over the medium term".........
So thats alright then.
I wonder if the mentioned patent challenges go ahead, if Stanleco have the will (or the cash) to fight them.
This RNS release is to me the catalyst of proof how pathetic the management of this company has been over the last 3 years.
The sp will now trip along at around 1p (if lucky) until they are taken over by someone who knows what their doing. That is if anyone wants them.
Falcothou
- 29 May 2007 08:23
- 24480 of 27111
Looks like some washing their hands of it and others trying to make a quick buck from the mm's mark down
garyble
- 29 May 2007 08:25
- 24481 of 27111
Takeover looking more and more likely to me at bargain basement price!
Could there be a clause in the partnership which erquires a level of consumption of Biotec products?
Haystack
- 29 May 2007 08:27
- 24482 of 27111
You couldn't make it up. What will become of SEO? Will it turn into a cash shell and just become dormant. This was always going to be a loser. Just another company with investors in love with the technology and no hope of it being a real business. The list of such failed companies is very long. They have 11m in cash, but their market cap is 34m. This has some way to fall yet.
"Stanelco PLC said trading expectations for the full year will be 'adversely affected' by patent challenges"
"trials of its Greenseal product showed the application is unlikely to lead to commercial sales."
"The company put its plans to manufacture Biotec products in the US on hold"
for "further cost reductions are envisaged" read mass sackings!
ptholden
- 29 May 2007 08:32
- 24483 of 27111
Considering the update, I don't think a 50% mark down is unreasonable. Greenseal, the flagship product is dead and BIOTEC sales are zero. Difficult to see where significant revenues are going to come from.
greekman
- 29 May 2007 08:34
- 24484 of 27111
Might short this and buy back when the sp gets to half a groat.
At the rate its going 1 share will be worth the same as a bio-degradable carrier bag.
cynic
- 29 May 2007 08:36
- 24485 of 27111
not enough left in sp to short .... sure ain't gloating at others' misfortune, but .....
oblomov
- 29 May 2007 08:43
- 24486 of 27111
'the Stanelco sales and product pipeline is currently nascent '
Nascent - thats a nice word. ''being born or beginning; "the nascent chicks"; "a nascent insurgency" my dictionary says.
Still-born more like!
So, Greenseal is dead and so are the MMF's. What's left?
Surely SEO are obliged to build these MMF's given that it was largely on the strength of doing so that funding was sought and achieved last September.
Any thoughts on what can be done about that? I'd like my money back, and I expect Schroders would as well! I'd rather the remaining 11m was split amongst shareholders and they shut up shop now than continue till its gone and wasted!
Dont like to say 'I told you so' but regarding the patents I have been saying there could be problems ahead for the last 18 months or more as many will know. Some of you even managed to get a gagging oder on me over on FYA!
Garyble - takeover? Who would want to buy this heap of barnacles?
BTW - anyone heard from Eric lately - does he still work for Schroders?